Outsourcing

A presentation by Jim Miller will offer a detailed review of the contract services landscape.

Rentschler Biotechnologie expands European manufacturing capabilities with GE Healthcare Life Sciences bioprocess technologies.

Recipharm makes a strategic investment in Synthonics and partners in development of novel compounds.

Pfizer announces that its Phase III trial for Ibrance met its primary endpoint and was ended early due to efficacy based on an assessment by an independent Data Monitoring Committee.

Cornell Stamoran, Catalent Pharma Solutions vice-president, is elected to the board of trustees of the Pharma & Biopharma Outsourcing Association.

Big service providers get bigger faster thanks to Big Pharma.

Rentschler Biotechnologie launches 2000-L single-use bioreactor and announces additional expansion.

Xcellience receives approval to handle both analytical and manufacturing of DEA Scheduled products.

As an affiliate member, TraceLink brings serialization expertise to the Pharma & Biopharma Outsourcing Association.

Patheon cites expanded API services with acquisition of IRIX Pharmaceuticals.

Steve Nole joins Grand River Aseptic Manufacturing as director of manufacturing.

WellSpring Pharma Services has announced the appointment of David Mayers as president.

A facility expansion adds space for production of Repligen’s tangential flow system.

The Pharma & Biopharma Outsourcing Association announced its support of legislation that would preserve FDA user fees from sequestration.

SGS Life Science Services adds analytical methods to identify amino acid impurities in bio/pharmaceutical manufacturing at facility in Germany.

Novasep has entered into an agreement with Celladon to provide scale-up and pre-validation studies for the drug substance for MYDICAR.

The fast growth of the global biopharmaceutical market has prompted global pharmaceutical and biotechnology companies to increase their R&D investment in biologics.

Protecting workers, patients, and the environment requires advanced technologies.

Is there enough talent to go around?

The company has increased capacity for cold storage and controlled drug substances handling at its European facilities.

SGS has invested in additional modules for its COBAS 6000 analysis system in a move to expand its biomarker analytical capabilities at its Poitiers facility in France.

Careful selection of a contract packager should include interviews, surveys, and on-site visits.

The agency releases five draft guidance documents related to drug compounding and repackaging.

Market forces may limit the success of CMOs.

Biomanufacturers are seeking more innovation and expertise from their CMO partners.